“…For patients, the experience of diagnosis and first-line treatment is traumatic and often results in long-term side effects due to the aggressive nature of many of the treatment options, which can have a significant impact on quality of life. 6,7 Unfortunately, not all patients will achieve a complete remission with first-line treatment (referred to as "refractory" disease). Furthermore, for around 50% of people with AML 8 and 50% of adults with ALL that achieve remission, 9 the acute leukemia later returns (referred to as a "relapse").…”